Accéder au contenu
Merck

Effect of phencyclidine derivatives on anxiety-like behavior using an elevated-plus maze test in mice.

Advances in clinical and experimental medicine : official organ Wroclaw Medical University (2012-12-12)
Ramin Hajikhani, Abbas Ahmadi, Nima Naderi, Kayvan Yaghoobi, Zahra Shirazizand, Nazereh M Rezaee, Babak N Niknafs
RÉSUMÉ

The study attempted to investigate the anti-anxiety activities of Phencyclidine (1-(1-phenylcyclohexyl) piperidine, PCP, I) and some of its derivatives (M, F, L, B, S, P) with the elevated-plus maze (EPM) Test. Phencyclidine and its derivatives (M, F, L, B, S, P) were administrated intraperitoneally (i.p.) at a dose of 10 mg/kg to male mice. Anxiety-like behaviors were assessed using the elevated-plus maze test. EPM results revealed an increase in open arms time spent after applying PCP and M, L, P, and B compounds at the administered dosage. Moreover, an increase in the number of open arm entries was observed with M, P, and B compounds. The P, B and S compounds increased the locomotion of animals, too, which might be considered as the side effect to the compounds. Considering the elevated-plus maze results, it was concluded that M and L compounds could be considered as a potential anxiolytic with less side effects due to a probable high electron donation of the methoxy group, as well as the hydrophilic properties of hydroxyl groups on these compounds.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Supelco
PCP (Phencyclidine) solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
Phencyclidine hydrochloride